Recent News

By Region: North America

Plumbing the mysteries of Plum Island

(CBS News) A place that’s off-limits to most of us was in the news this past week. The federal government announced it has granted a license for a new foot-and-mouth vaccine . . . a vaccine developed at the Plum Island Animal Disease Center. With correspondent John Miller we get a rare inside look: Plum  Read More »

FMD vaccine earns conditional approval

(CattleNetwork.com) The US Department of Agriculture’s Animal and Plant Health Inspection Service (APHIS) issued a conditional license for GenVec, Inc.’s foot-and-mouth disease vaccine for use in cattle, the company announced June 7. GenVec also announced that Merial, the animal health division of Sanofi, has the rights to develop and commercialize GenVec’s FMD vaccine for use  Read More »

NRC Report Warns of Shortfall in Veterinarians Trained in Biodefense

(Global Security Newswire) An analysis released last week by the independent National Research Council draws attention to a potential lack of veterinarians who specialize in animal disease research, which could have serious ramifications should terrorists ever seek to attack the U.S. food supply. In excess of 50 percent of those enrolled in veterinary schools pursue  Read More »

Gene Therapy Society Looking to NIH to Revisit Role of the Recombinant DNA Advisory Committee

(Genetic Engineering News) Goal is to restrict involvement in clinical trials and focus the RAC on questions of public concern. The principal U.S. professional society representing gene therapists is awaiting word from NIH about whether or not there will be re-examination of the role of its Recombinant DNA Advisory Committee (RAC). They aim to limit  Read More »

Novel Antimicrobials for Killing Anthrax

(Global Biodefense) The CDC’s Division of High-Consequence Pathogens and Pathology (DHCPP) Bacterial and Special Pathogens Branch this week announced its intent to issue a purchase order to the University of Michigan Life Sciences Institute for the production of novel antimicrobials for specific killing of Bacillus anthracis.